Socio-demographic indicators of self-reported health based on EQ-5D-3L: A cross-country analysis of population surveys from 18 countries.

EQ-5D-3L EuroQol equity health inequalities health-related quality of life population health self-reported health sociodemographic indicators

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2022
Historique:
received: 01 06 2022
accepted: 25 11 2022
entrez: 23 1 2023
pubmed: 24 1 2023
medline: 25 1 2023
Statut: epublish

Résumé

Generic health-related quality of life instruments, such as the EQ-5D, are increasingly used by countries to monitor population health via general population health surveys. Our aim was to demonstrate analytic options to measure socio-demographic differences in self-reported health using the EuroQol Group's archive of EQ-5D-3L population surveys that accumulated over the past two decades. Analyses captured self-reported EQ-5D-3L data on over 100,000 individuals from 18 countries with nationally representative population surveys. Socio-demographic indicators employed were age, sex, educational level and income. Logistic regression odds ratios and the health concentration index methodology were used in the socio-demographic analysis of EQ-5D-3L data. Statistically significant socio-demographic differences existed in all countries ( The EQ-5D-3L was shown to be a powerful multi-dimensional instrument in the analyses of socio-demographic differences in self-reported health using various analytic methods. It offered a unique insight of inequalities by health dimensions.

Sections du résumé

Background UNASSIGNED
Generic health-related quality of life instruments, such as the EQ-5D, are increasingly used by countries to monitor population health via general population health surveys. Our aim was to demonstrate analytic options to measure socio-demographic differences in self-reported health using the EuroQol Group's archive of EQ-5D-3L population surveys that accumulated over the past two decades.
Methods UNASSIGNED
Analyses captured self-reported EQ-5D-3L data on over 100,000 individuals from 18 countries with nationally representative population surveys. Socio-demographic indicators employed were age, sex, educational level and income. Logistic regression odds ratios and the health concentration index methodology were used in the socio-demographic analysis of EQ-5D-3L data.
Results UNASSIGNED
Statistically significant socio-demographic differences existed in all countries (
Conclusion UNASSIGNED
The EQ-5D-3L was shown to be a powerful multi-dimensional instrument in the analyses of socio-demographic differences in self-reported health using various analytic methods. It offered a unique insight of inequalities by health dimensions.

Identifiants

pubmed: 36684894
doi: 10.3389/fpubh.2022.959252
pmc: PMC9853521
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

959252

Informations de copyright

Copyright © 2023 Szende, Janssen, Cabases, Ramos-Goni and Burström.

Déclaration de conflit d'intérêts

AS is employed by Labcorp. MJ works as a part-time freelance member for the scientific support team for the EuroQol Business Office. JR-G is employed by Maths in Health B.V. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Qual Life Res. 2022 Mar;31(3):697-712
pubmed: 34628587
J Health Econ. 2003 Jan;22(1):61-87
pubmed: 12564718
BMJ. 1998 Mar 7;316(7133):736-41
pubmed: 9529408
Value Health. 2009 Nov-Dec;12(8):1187-93
pubmed: 19659703
Front Public Health. 2021 Nov 04;9:744405
pubmed: 34805069
Health Econ. 2005 Aug;14(8):831-50
pubmed: 15712264
Scand J Public Health. 2009 Jul;37(5):467-74
pubmed: 19535407
Qual Life Res. 2006 Oct;15(8):1403-14
pubmed: 16960751
Health Econ. 2004 Mar;13(3):297-301
pubmed: 14981654
PLoS One. 2019 Apr 29;14(4):e0214283
pubmed: 31034491
Med Care. 2009 Feb;47(2):255-61
pubmed: 19169128
PLoS One. 2022 Jul 28;17(7):e0272252
pubmed: 35901071
Health Econ. 1999 Mar;8(2):117-26
pubmed: 10342725
Int J Equity Health. 2014 May 19;13:41
pubmed: 24885378
Value Health. 2011 Dec;14(8):1142-5
pubmed: 22152185
Front Public Health. 2021 Dec 20;9:780753
pubmed: 34988055
N Engl J Med. 2008 Jun 5;358(23):2468-81
pubmed: 18525043
Med Care. 2005 Jul;43(7):736-49
pubmed: 15970790
Int J Equity Health. 2007 Dec 18;6:23
pubmed: 18088434
Health Qual Life Outcomes. 2019 Apr 18;17(1):69
pubmed: 30999899
Soc Sci Med. 1991;33(5):545-57
pubmed: 1962226
J Health Econ. 2010 Jan;29(1):151-7
pubmed: 20061039
Value Health. 2017 Jan;20(1):174-177
pubmed: 28212959
Appl Health Econ Health Policy. 2022 Nov;20(6):857-866
pubmed: 35994209
Lancet. 1998 Apr 4;351(9108):1009-14
pubmed: 9546506
Qual Life Res. 2018 Nov;27(11):2859-2871
pubmed: 30196340
Int J Health Policy Manag. 2016 Jan 21;5(5):301-8
pubmed: 27239879
Health Econ. 2004 Jul;13(7):649-56
pubmed: 15259044
Soc Sci Med. 2004 Oct;59(7):1423-33
pubmed: 15246171
Qual Life Res. 2011 Apr;20(3):309-20
pubmed: 21042861
J Epidemiol Community Health. 2017 Jun;71(6):565-575
pubmed: 27682963
Health Policy. 1990 Dec;16(3):199-208
pubmed: 10109801
Orv Hetil. 2003 Aug 24;144(34):1667-74
pubmed: 14528840

Auteurs

Agota Szende (A)

Global Health Economics and Outcomes Research, Labcorp, Leeds, United Kingdom.

Mathieu F Janssen (MF)

Medical Psychology and Psychotherapy, Erasmus MC, Rotterdam, Netherlands.
EuroQol Group, Rotterdam, Netherlands.

Juan Cabases (J)

Department of Economics, Public University of Navarra, Pamplona, Spain.

Juan M Ramos-Goni (JM)

Maths in Health B.V., Rotterdam, Netherlands.

Kristina Burström (K)

Health Outcomes and Economic Evaluation Research Group, Stockholm Centre for Healthcare Ethics, Department of Learning, Informatics, Management, and Ethics, Karolinska Institutet, Stockholm, Sweden.
Equity and Health Policy Research Group, Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH